Diana DeGette actually said...

data challenges we identified in our 2008 report continue to make it difficult for FDA to accurately identify establishments subject to insp...

Because the FDA can't possibly test every new drug that comes into the U.S., inspections of drug manufacturers abroad are a critical way to ...

This hearing should not be interpreted as an indictment of foreign drug manufacturing generally.

I think that'd be really helpful.